SPRY
ARS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.62
−0.88%0
Insider buys (3m)
2
Insider sells (3m)
-$283.6K
Net value (3m)
-34.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Smith Margaret Ekins · officer: Chief Commercial Officer | A-Award | 1,001,738 | $5.77 |
| Jul 2, 2026 | Casale Donn · officer: President | A-Award | 898,456 | $7.96 |
| Jun 26, 2026 | Thompson Peter A. · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | SCHNEIDER PHILLIP M · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | Shawver Laura · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | Kelly Michael · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | Islam Saqib · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 30,000 | $11 |
| Jun 26, 2026 | Dadoo Rajeev · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | SAUNDERS BRENT L · director | A-Award | 30,000 | $11 |
| Jun 26, 2026 | Shah Pratik · director | A-Award | 30,000 | $11 |
| Jun 12, 2026 | Fitzpatrick Alexander A · officer: Chief Legal Officer | Sale | 3,355 | $10 |
| Jun 12, 2026 | Karas Eric · officer: Chief Commercial Officer | Sale | 25,000 | $10 |
| Jun 12, 2026 | Karas Eric · officer: Chief Commercial Officer | M-Exempt | 25,000 | $1.50 |
| Jan 5, 2026 | Dorsey Brian · officer: Chief Operating Officer | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Fitzpatrick Alexander A · officer: Chief Legal Officer | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Karas Eric · officer: Chief Commercial Officer | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Tanimoto Sarina · 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Tanimoto Sarina · 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | 875,000 | $11 |
| Jan 5, 2026 | Chakma Justin · officer: Chief Business Officer | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Scott Kathleen D. · officer: Chief Financial Officer | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Lowenthal Richard E · director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | 240,000 | $11 |
| Jan 5, 2026 | Lowenthal Richard E · director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | 875,000 | $11 |
| Nov 14, 2025 | Chakma Justin · officer: Chief Business Officer | Sale | 136,380 | $8.86 |
| Nov 14, 2025 | Dorsey Brian · officer: Chief Operating Officer | M-Exempt | 21,828 | $0.64 |
| Nov 14, 2025 | Dorsey Brian · officer: Chief Operating Officer | Sale | 21,828 | $8.71 |
| Nov 14, 2025 | Chakma Justin · officer: Chief Business Officer | M-Exempt | 30,000 | $0.84 |
| Nov 14, 2025 | Chakma Justin · officer: Chief Business Officer | Sale | 30,000 | $8.91 |
| Aug 22, 2025 | Lowenthal Richard E · director, 10 percent owner, officer: PRESIDENT AND CEO | Sale | 50,000 | $14 |
| Aug 22, 2025 | Scott Kathleen D. · officer: Chief Financial Officer | M-Exempt | 12,500 | $1.50 |
Institutional positioning
13F filings over the trailing two quarters
New 79Increased 136Reduced 115Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,860,977 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,860,977 | May 15, 2026 |
| Rubric Capital Management LP | Increased | 8,540,861 | Aug 14, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 8,288,510 | Aug 14, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 8,288,510 | May 15, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | Increased | 8,000,000 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Unchanged | 7,503,812 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 7,503,812 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 5,982,919 | May 15, 2026 |
| BlackRock, Inc. | Increased | 5,311,319 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 5,012,254 | May 13, 2026 |
| Tyro Capital Management LLC | Increased | 4,459,337 | Aug 13, 2026 |
| Aberdeen Group plc | Increased | 4,170,629 | Jul 31, 2026 |
| ABRDN PLC | Increased | 4,113,617 | Apr 29, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 4,012,903 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026